Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TME”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Testing effectiveness (Phase 2)Study completedNCT00828672
What this trial is testing

Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Universitaire Ziekenhuizen KU Leuven 84
Not applicableStudy completedNCT02252250
What this trial is testing

Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer

Who this might be right for
Rectal Neoplasms
Third Military Medical University 70
Large-scale testing (Phase 3)Study completedNCT01609504
What this trial is testing

ELRR by TEM Versus Laparoscopic TME in iT2N0M0 SMALL LOW RECTAL CANCER

Who this might be right for
Rectal Cancer
University of Roma La Sapienza 283
Not applicableStudy completedNCT00910143
What this trial is testing

Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer
Insel Gruppe AG, University Hospital Bern 194
Not applicableActive Not RecruitingNCT06533670
What this trial is testing

TME Alteration in HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerChemotherapy Effect
Seoul National University Hospital 30
Not applicableLooking for participantsNCT02292641
What this trial is testing

Beyond TME Origins

Who this might be right for
NeoplasmsAdenocarcinomaCarcinoma
Imperial College London 383
Not applicableActive Not RecruitingNCT03144765
What this trial is testing

Multicenter Phase II Study of Transanal TME (taTME)

Who this might be right for
Rectal CancerSurgery
Icahn School of Medicine at Mount Sinai 100
Large-scale testing (Phase 3)UnknownNCT02736942
What this trial is testing

COLOR III Trial: Transanal vs Laparoscopic TME

Who this might be right for
Rectal CarcinomaSurgery
Amsterdam UMC, location VUmc 1,104
Testing effectiveness (Phase 2)WithdrawnNCT06767956
What this trial is testing

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy

Who this might be right for
Non Hodgkin Lymphoma
University of Pittsburgh
Not applicableStudy completedNCT02550769
What this trial is testing

Study of NOTES-TME Versus L-LAR in Rectal Cancer

Who this might be right for
Rectal Cancer
Corporacion Parc Tauli 116
Testing effectiveness (Phase 2)Looking for participantsNCT05516628
What this trial is testing

Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 30
Not applicableLooking for participantsNCT07651553
What this trial is testing

Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision

Who this might be right for
Rectal Cancer PatientsRobotic Assisted Intervention
Sun Yat-sen University 216
Not applicableNot Yet RecruitingNCT06613399
What this trial is testing

Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.

Who this might be right for
Rectal Cancer
The First Affiliated Hospital with Nanjing Medical University 324
Testing effectiveness (Phase 2)Looking for participantsNCT06157996
What this trial is testing

Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore

Who this might be right for
Gastric Cancer
Nanfang Hospital, Southern Medical University 92
Testing effectiveness (Phase 2)Temporarily pausedNCT06694454
What this trial is testing

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)UnknownNCT03242187
What this trial is testing

Trans-anal Versus Laparoscopic TME for Mid and Low Rectal Cancer

Who this might be right for
Rectal Cancer
Mansoura University 30
Not applicableLooking for participantsNCT03587480
What this trial is testing

Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy

Who this might be right for
Rectal Neoplasm Malignant
Sixth Affiliated Hospital, Sun Yat-sen University 250
Testing effectiveness (Phase 2)UnknownNCT04911517
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by TME for LARC.

Who this might be right for
Colorectal Neoplasms
Beijing Friendship Hospital 50
Not applicableStudy completedNCT01836926
What this trial is testing

TaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.

Who this might be right for
Rectal Cancer
Osama Mohammad Ali ElDamshety 110
Not applicableUnknownNCT05749497
What this trial is testing

Prediction of the Chronicization of Radiation-induced Acute Intestinal Injury Based on the Expression Level of lncRNA

Who this might be right for
Radiation-induced Intestinal Injury
Sixth Affiliated Hospital, Sun Yat-sen University 200
Next Page